Skip to content

CONSERVE® 38AM4004Recalls & reported problems

Microport Orthopedics Inc. · CONSERVE® A-CLASS® BFH® HEAD SHORT NECK 40MM · Class 3 · Implant

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI M68438AM40041), received between Jul 17, 2019 and Aug 6, 2019 — classified as 2 injuries.

The most frequently reported specific device problem is “Material Disintegration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Material Disintegration1
  • Unstable1

Patient problems

  • Loss of Range of Motion2
  • Reaction1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 6, 2019Unstable; Unstable

    ALLEGEDLY THE PATIENT WAS REVISED PAIN ASSOCIATED WITH DECREASED RANGE OF MOTION; DIFFICULTY AMBULATING AND INSTABILITY. (RIGHT). HEAD WAS REMOVED AND REPLACED WITH OUR 28MM +3.5MM HEAD AND STRYKERS DUAL MOBILITY. CULTURES TAKEN.

    Patient problems: Loss of Range of Motion

    MAUDE report 8865597 ↗
  • InjuryJul 17, 2019Material Disintegration; Material Disintegration

    ALLEGEDLY THE PATIENT WAS REVISED 8 YEARS LATER ON (B)(6) 2017 BY DR. (B)(6). THE INDICATION FOR THE REVISION WAS MECHANICAL COMPLICATIONS, BUT THE DOCTOR DID NOTE FINDING CONSISTENT METALLOSIS NEAR THE CUP. (LEFT).

    Patient problems: Loss of Range of Motion; Reaction

    MAUDE report 8798624 ↗

Other Prosthesis, Hip, Semi-Constrained (Metal Cemented Acetabular Component) devices

All Prosthesis, Hip, Semi-Constrained (Metal Cemented Acetabular Component) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.